GSK plc Operating Cash Flow for the year ending December 31, 2024: USD 8.20 B

GSK plc Operating Cash Flow is USD 8.20 B for the year ending December 31, 2024, a -4.78% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • GSK plc Operating Cash Flow for the year ending December 31, 2023 was USD 8.61 B, a -3.75% change year over year.
  • GSK plc Operating Cash Flow for the year ending December 31, 2022 was USD 8.95 B, a -16.86% change year over year.
  • GSK plc Operating Cash Flow for the year ending December 31, 2021 was USD 10.76 B, a -6.65% change year over year.
  • GSK plc Operating Cash Flow for the year ending December 31, 2020 was USD 11.53 B, a 8.47% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities